John Kinnaird Ferguson MacLean

Title: John Kinnaird Ferguson MacLean: Innovator in Pharmaceutical Chemistry

Introduction

John Kinnaird Ferguson MacLean is a notable inventor based in Newhouse, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work primarily focuses on developing innovative compounds for medical applications.

Latest Patents

One of MacLean's latest patents involves the invention of (pyrrolidin-2-yl)phenyl derivatives. This invention relates to compounds that can be used in pharmaceutical compositions for treating various types of pain, including neuropathic and inflammatory pain. Another significant patent is for substituted thieno[2,3-d]pyrimidines, which serve as AMPA modulators. These compounds are designed to enhance synaptic responses mediated by AMPA receptors, making them potentially useful in treating psychiatric diseases such as schizophrenia, depression, and Alzheimer's disease.

Career Highlights

Throughout his career, MacLean has worked with various companies, including N.V. Organon. His experience in the pharmaceutical industry has allowed him to develop and patent innovative solutions that address critical health issues.

Collaborations

MacLean has collaborated with notable colleagues, including Craig Jamieson and Elizabeth Margaret Moir. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

John Kinnaird Ferguson MacLean is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to improving medical treatments and addressing significant health challenges.